SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-23-006247
Filing Date
2023-05-09
Accepted
2023-05-09 13:05:09
Documents
17
Period of Report
2023-05-09
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp_8k-050923.htm   iXBRL 8-K 42261
2 CERTIFICATE OF CHANGE OF TONIX PHARMACEUTICALS HOLDING CORP., DATED MAY 8, 2023 ex3-01.htm EX-3.01 3321
3 PRESS RELEASE OF THE COMPANY, DATED MAY 9, 2023 ex99-01.htm EX-99.01 11837
7 GRAPHIC ex3-01_001.jpg GRAPHIC 337753
8 GRAPHIC ex3-01_002.jpg GRAPHIC 307916
9 GRAPHIC ex3-01_003.jpg GRAPHIC 747414
  Complete submission text file 0001387131-23-006247.txt   2158994

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20230509.xsd EX-101.SCH 3203
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20230509_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20230509_pre.xml EX-101.PRE 22343
11 EXTRACTED XBRL INSTANCE DOCUMENT tnxp_8k-050923_htm.xml XML 3580
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 23901131
SIC: 2834 Pharmaceutical Preparations